Description
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) modified to extend the peptide’s half-life significantly. Through the inclusion of DAC, this 30-amino acid peptide remains active in circulation for several days, allowing for sustained GH release in research models. CJC-1295 w/ DAC is widely studied for its ability to promote growth hormone secretion, influence IGF-1 production, and model long-acting endocrine signaling. Provided in a 5mg lyophilized format, this compound is intended strictly for advanced laboratory-based in vitro applications.
Reviews
There are no reviews yet.